Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Ting Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3795-939X; OpenAlex author ID A5070171319. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 3 papers · 2023: none · 2024: none · 2025: 1 paper

Papers 7

  1. F41, a Novel Fungal Indole-Diterpenoid, Overcomes Gemcitabine Resistance in Pancreatic Cancer by Inducing ER Stress. Co-author DOI 10.3390/ijms262110694↗
  2. Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming. Co-author DOI 10.1016/j.actbio.2022.03.050↗
  3. Comprehensive Analysis of 5-Methylcytosine (m5C) Regulators and the Immune Microenvironment in Pancreatic Adenocarcinoma to Aid Immunotherapy. Co-author DOI 10.3389/fonc.2022.851766↗
  4. TSPAN1-elevated FAM110A promotes pancreatic cancer progression by transcriptionally regulating HIST1H2BK. Co-author DOI 10.7150/jca.66404↗
  5. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer. Co-author DOI 10.3389/fimmu.2021.769425↗
  6. Expression of DEK in pancreatic cancer and its correlation with clinicopathological features and prognosis. Co-author DOI 10.7150/jca.27405↗
  7. Interferon Gamma Inhibits CXCL8-Induced Proliferation and Migration of Pancreatic Cancer BxPC-3 Cell Line via a RhoGDI2/Rac1/NF-κB Signaling Pathway. Co-author DOI 10.1089/jir.2018.0070↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wuli Zhao · 1 shared paper, 2025 · strength 0.27
  2. Zixiang Gao · 1 shared paper, 2025 · strength 0.27
  3. Li Liu · 1 shared paper, 2025 · strength 0.27
  4. Yongdong Guo · 2 shared papers, 2021–2022 · strength 0.24
  5. Yang Song · 2 shared papers, 2021–2022 · strength 0.24
  6. Junqiang Li · 2 shared papers, 2021–2022 · strength 0.24
  7. Ronglin Wang · 2 shared papers, 2021–2022 · strength 0.24
  8. Cheng Yang · 2 shared papers, 2021–2022 · strength 0.24
  9. Lei Hua · 2 shared papers, 2021–2022 · strength 0.24
  10. Haichuan Su · 2 shared papers, 2021–2022 · strength 0.24
  11. Guoping Ding · 2 shared papers, 2018–2019 · strength 0.20
  12. Liping Cao · 2 shared papers, 2018–2019 · strength 0.20
  13. Zhirong Zhang · 1 shared paper, 2022 · strength 0.17
  14. Rongping Zhang · 1 shared paper, 2022 · strength 0.17
  15. Qin He · 1 shared paper, 2022 · strength 0.17
  16. Shensen Wang · 1 shared paper, 2022 · strength 0.16
  17. Xinhui Liu · 1 shared paper, 2022 · strength 0.16
  18. Aamir Ali Khan · 1 shared paper, 2022 · strength 0.16
  19. Hua Huang · 1 shared paper, 2022 · strength 0.16
  20. Zhengrong Wu · 1 shared paper, 2019 · strength 0.11
  21. Liangjing Zhou · 1 shared paper, 2018 · strength 0.09
  22. Mingjie Zhang · 1 shared paper, 2018 · strength 0.09
  23. Xiaodong Xu · 1 shared paper, 2018 · strength 0.09
  24. Shengnan Jia · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.